Biochemical screening for congenital defects. [Obstet Gynecol Clin North Am. 2004]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: Obstet Gynecol Clin North Am. 2004 Dec;31(4):857-72, xi. Links

Biochemical screening for congenital defects.

Bahado-Singh RO, Sutton-Riley J.

Department of Obstetrics & Gynecology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. bahadoro@ucmail.uc.edu

This article discusses biochemical screening for congenital defects. Biochemical screening remains the standard for estimating the risk of aneuploidy in pregnancy. The combination of first and second trimester markers promises to further improve diagnostic accuracy for anomaly detection.

PMID: 15550339 [PubMed - indexed for MEDLINE]

Triploidy identified through second-trimester serum screening.
Prenat Diagn. 2005 Mar; 25(3):229-33.

[Prenat Diagn. 2005]
Prenatal biochemical diagnostics of inborn developmental defects.
Sb Lek. 1994; 95(4):277-83.

[Sb Lek. 1994]
Maternal serum screening in Ontario using the triple marker test.
J Med Screen. 2003; 10(3):107-11.

[J Med Screen. 2003]
ReviewPrenatal screening for Down syndrome and neural tube defects in twin pregnancies.
Prenat Diagn. 2005 Sep; 25(9):740-5.

[Prenat Diagn. 2005]
ReviewFirst-trimester screening: an overview.
J Histochem Cytochem. 2005 Mar; 53(3):281-3.

[J Histochem Cytochem. 2005]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Biochemical screening for congenital defects.Biochemical screening for congenital defects.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Biochemical screening for congenital defects.

Related articles

Recent Activity